FRNM

9.3605.69%
DP

Deepa Pakianathan

Independent Director

Dr. Deepa Pakianathan, Ph.D., is Director of Freenome, Inc since April 2019. Dr. Pakianathan holds Ph.D. in Immunology from Wake Forest University. She has M.S. in Immunology from Wake Forest University. She has B.S. in Immunology, Microbiology from University of Mumbai. She has M.S. in Biophysics from University of Mumbai. Prior to joining Delphi, Pakianathan was a Vice President in the healthcare group at J.P. Morgan where she was involved in several large healthcare merger and acquisition transactions and led public offerings for biotechnology companies. She serves on the boards of directors of Calithera Biosciences, Inc. (Nasdaq: CALA), Karyopharm Therapeutics, Inc. (Nasdaq: KPTI), Mereo Biopharma Group plc (formerly OncoMed Pharmaceuticals, Inc.) (Nasdaq: MREO) and Theravance Biopharma, Inc. (Nasdaq: TBPH) and serves as the Executive Vice Chair and Treasurer on the Board of Trustees of the San Francisco Conservatory of Music. In the past five years, she also served on the board of directors of FS Development Corp. (now Gemini Therapeutics, Inc.), Alder Biopharmaceuticals, Inc. and Alexza Pharmaceuticals, Inc.

Positions